The store will not work correctly when cookies are disabled.
5-(2-amino-5-pivaloyloxazol-4-yl)furan-2-ylphosphonic acid
ID: ALA3218209
PubChem CID: 90665556
Max Phase: Preclinical
Molecular Formula: C12H15N2O6P
Molecular Weight: 314.23
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)C(=O)c1oc(N)nc1-c1ccc(P(=O)(O)O)o1
Standard InChI: InChI=1S/C12H15N2O6P/c1-12(2,3)10(15)9-8(14-11(13)20-9)6-4-5-7(19-6)21(16,17)18/h4-5H,1-3H3,(H2,13,14)(H2,16,17,18)
Standard InChI Key: XKKRDYPJKAIRNM-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
7.4537 -5.3696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2709 -5.3696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5253 -4.5928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8623 -4.1107 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2036 -4.5928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3028 -4.3414 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
9.9094 -4.8890 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8901 -3.6278 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8806 -3.7558 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4263 -4.3407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1720 -3.5666 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3539 -3.5668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1026 -4.3456 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7663 -4.8240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8728 -2.9062 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7698 -5.6446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4790 -6.0506 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0638 -6.0561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3544 -5.6503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0670 -6.8733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3501 -6.4591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
3 6 1 0
6 7 2 0
6 8 1 0
6 9 1 0
5 10 1 0
11 12 2 0
10 11 1 0
12 13 1 0
13 14 1 0
14 10 2 0
12 15 1 0
16 17 2 0
14 16 1 0
16 18 1 0
18 19 1 0
18 20 1 0
18 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 314.23 | Molecular Weight (Monoisotopic): 314.0668 | AlogP: 1.55 | #Rotatable Bonds: 3 |
Polar Surface Area: 139.79 | Molecular Species: ACID | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.40 | CX Basic pKa: ┄ | CX LogP: 0.22 | CX LogD: -2.77 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.57 | Np Likeness Score: -0.16 |
References
1. Dang Q, Kasibthatla SR, Jiang T, Taplin F, Gibson T, Potter SC, van Poelje PD, Erion MD. (2011) Oxazole phosphonic acids as fructose 1,6-bisphosphatase inhibitors with potent glucose-lowering activity, 2 (4): [10.1039/C0MD00269K] |